Access Curated Private Market Opportunities
Award-winning Platform Empowering Innovation, Capital and Ambition, Globally
-
0
+
Investors & Deal Makers
-
0
Unicorns
-
0
Year track record
POWERED BY CapitalHQTM
Utilise our cutting-edge AI-powered platform to access curated Private Opportunities. Discover Startups, Scaleups, Fund Managers, Private Equity, Property, Small Cap Listed and Secondary Market Opportunities
Join an exclusive ecosystem of High-Net-Worth, Professional, Institutional, VC and Family Office Investors. Receive personalised deal flow, streamlined information access and access to investment insights from leading global Fund Managers and Investors
Access Exclusive Private Opportunities
Get access to curated growth companies, property opportunities, alternative funds, investment insights and exclusive investor networking events
- Free Account Set up
- No transaction fees
- Direct Access to CEOs and Managers
- Curated Global Deal Flow
QBiotics Group
SoHi Partners
The Insides Company
Medigrowth – Equity
CosmoInnovations
Kitea Health
Cortical Dynamics
Bioshore Ventures
Saiiv Monitoring Solutions
NanoFynd Pty Ltd
Navi Medical Technologies
Ferronova Series A
A Personalised Pipeline of Opportunities
Let our AI/ML provide you with personalised, exclusive and consistent deal flow
QBiotics Group
SoHi Partners
The Insides Company
Medigrowth – Equity
CosmoInnovations
Kitea Health
Cortical Dynamics
Bioshore Ventures
Saiiv Monitoring Solutions
NanoFynd Pty Ltd
Navi Medical Technologies
Ferronova Series A
- Overview
- Market Opportunity
- Competitive Advantage
- Highlights and Milestones
- Investment Offering
Saiiv Monitoring Solutions
Streamlined Investor Experience
Access the information you want and need, in a structured, clear format.
Trusted by hundreds of companies worldwide
Our international clientele includes leading emerging growth companies, funds, governments, universities, incubators, accelerators and advisory firms.
Premier Investor Events and Conferences
See exclusive pitches, product demos, and talk with founders
In person or online
Life Science Investor Day – Part of Emergence 2026 Sydney
EMERGENCE – Investment Conference – SYDNEY 2026
As seen in
News and announcements
Our Clients’ Major Breakthrough and Milestones
Wholesale Investor and MTPConnect Announce Strategic Partnership to Accelerate Investment in Australia’s Life Sciences Sector
Wholesale Investor and MTPConnect announce a landmark strategic partnership to bridge the funding gap in Australia’s life sciences sector. The collaboration creates a comprehensive capital engagement program, culminating in the Life Sciences Investor Day at the Emergence 2026 Conference
Steve Torso on Why Brevity Wins in Capital Raising
In the relentless pursuit of investment, founders often believe more information equates to more persuasion. However, according to Steve Torso, Co-founder and Managing Director at CapitalHQ and Wholesale Investor, the science of successful capital raising dictates a counter-intuitive approach: less is more, especially in the initial stages. “When you’re actually communicating your business, you’ve got […]
Wholesale Investor and CapitalHQ Sign Exclusive Master Licence with inQ Innovation Global to Provide Access to India’s High-Growth Startup Market
Wholesale Investor and inQ Innovation have forged a strategic partnership, granting global investors direct access to India’s rapidly expanding innovation ecosystem. This exclusive three-year agreement leverages CapitalHQ’s technology to streamline fundraising for Indian startups and expand deal flow for WI’s 45,000-strong investor network, aligning with India’s 2030 Vision for economic growth and innovation.
EBR Systems: Aussie Medtech Ready to Disrupt $3.6B Heart Failure Market with Leadless Pacemaker
Andrew Shute, Senior Vice President of Business Development at EBR Systems, is confident that his Australian medical device company is poised to make a significant impact on the global cardiac rhythm management market. The focus? A novel leadless pacemaker designed to revolutionise treatment for heart failure patients. After years of development and rigorous clinical trials, […]
See more exiting opportunities on CapitalHQ
Pictor
Powering diagnostics with protein signatures. Pictor is transforming health with its patented platform providing accessible, affordable, and scalable diagnostic solutions across the human and animal health verticals. PictArray can detect up to 10 diseases or biomarkers from one small serum, milk,…
ProxyTwin
ProxyTwin™ amplifies expertise. ProxyTwin is a digital twin that works for experts so they can help more people. We create advanced digital replicas of real individuals, enabling them to virtually attend meetings, deliver messages, and hold thousands of interactions simultaneously. Recently…
HorizonTwo Capital Partners
HorizonTwo Capital Partners is a private equity firm that specialises in advanced manufacturing companies.
The Insides Company
First-in-class medtech for intestinal failure. Seeking remaining $1M of a $5M round, on a AUD$17.2M pre-money valuation.
DCARB
We are aiming to raise $CAD5M to fund the ongoing commercialisation of the D100 unit, including working capital to fund the expected growth in sales, and a field trial of the DArc unit. This follows a successful Series B round completed in mid-2023.
Grabba Technologies Pty Ltd
Advanced manufacturer of biometric identity authorisation products and electronics supplier to defence industry. We invite expressions of interest for up to $10.0M in growth capital.
Backed By Leading Investment Groups and Family Offices
